Comparisons of gut microbiota profiles in wild-type and gelatinase B/matrix metalloproteinase-9-deficient mice in acute DSS-induced colitis
Open Access
- 3 September 2018
- journal article
- research article
- Published by Springer Nature in npj Biofilms and Microbiomes
- Vol. 4 (1) , 18
Abstract
Gut microbiota help to educate the immune system and a number of involved immune cells were recently characterized. However, specific molecular determinants in these processes are not known, and, reciprocally, little information exists about single host determinants that alter the microbiota. Gelatinase B/matrix metalloproteinase-9 (MMP-9), an innate immune regulator and effector, has been suggested as such a host determinant. In this study, acute colitis was induced in co-housed MMP-9-/- mice (n = 10) and their wild-type (WT) littermates (n = 10) via oral administration of 3% dextran sodium sulfate (DSS) for 7 days followed by 2 days of regular drinking water. Control mice (10 WT and 10 MMP-9-/-) received normal drinking water. Fecal samples were collected at time of sacrifice and immediately frozen at −80 °C. Microbiota analysis was performed using 16S rRNA amplicon sequencing on Illumina MiSeq and taxonomic annotation was performed using the Ribosomal Database Project as reference. Statistical analysis correcting for multiple testing was done using R. No significant differences in clinical or histopathological parameters were found between both genotypes with DSS-induced colitis. Observed microbial richness at genus level and microbiota composition were not significantly influenced by host genotype. In contrast, weight loss, disease activity index, cage, and phenotype did significantly influence the intestinal microbiota composition. After multivariate analysis, cage and phenotype were identified as the sole drivers of microbiota composition variability. In conclusion, changes in fecal microbiota composition were not significantly altered in MMP-9-deficient mice compared to wild-type littermates, but instead were mainly driven by DSS-induced colonic inflammation.Keywords
This publication has 39 references indexed in Scilit:
- Inhibition of gelatinase B/MMP-9 does not attenuate colitis in murine models of inflammatory bowel diseaseNature Communications, 2017
- Microbiota as Therapeutic TargetsDigestive Diseases, 2016
- Acute dextran sulfate sodium (DSS)‐induced colitis promotes gut microbial dysbiosis in miceJournal of Basic Microbiology, 2016
- Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitisImmunology, 2015
- Heterogeneity of the gut microbiome in mice: guidelines for optimizing experimental designFEMS Microbiology Reviews, 2015
- Passenger Mutations Confound Interpretation of All Genetically Modified Congenic MiceImmunity, 2015
- The Impact of the Gut Microbiota on Human Health: An Integrative ViewCell, 2012
- Inflammatory Bowel DiseaseNew England Journal of Medicine, 2009
- The gut microbiota shapes intestinal immune responses during health and diseaseNature Reviews Immunology, 2009
- Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseasesNature Reviews Drug Discovery, 2007